Empowering People to be Ambassadors of their Own Health Since 1997.


Weekly News

Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week.  Topics include all stories related to lung cancer as well as personal stories and events.

AstraZeneca lung cancer drug given green light in US

“A new lung cancer pill from AstraZeneca has been approved by US regulators, in a major boost for the British drugmaker.AZD9291, which will be sold as Tagrisso, is for advanced non-small-cell lung cancer, the most common form of lung cancer. Tagrisso targets a genetic mutation, known as T790M, that helps tumours evade current lung cancer pills. The drug will be made available to patients in the US as soon as possible and its price will be “comparable to other oral cancer therapies,” a spokeswoman said. AstraZeneca will reveal the price early next week.”

 Lung cancer patient shares her story in recognition of Lung Cancer Awareness Month

PETOSKEY — “Petoskey resident Dayle Heintschel considered herself a very healthy 54-year-old woman, until March 4 of this year when routine X-rays showed an abnormality in her left lung.”

‘I want to help change the face of lung cancer’

“When she was told she had lung cancer, Elizabeth Dessureault says, she was unable to process what she was hearing. “It didn’t make sense to me that a 26-year-old, healthy, non-smoker could get lung cancer.””

Death of NYPD Lt. Marci Simms Raises Lung Cancer Awareness

Family and friends described Marci Simms as a hero, a fighter — and now an angel.

How to encourage loved ones to get spiral CT lung cancer screening

“Spiral CT lung cancer screening can help save lives. Current smokers (or former smokers who quit in the past 15 years) and those who smoke about 30 packs of cigarettes a year can participate in lung cancer screening.”

Kentucky LEADS Collaborative Implements Multipronged Approach to Lung Cancer in Kentucky

LEXINGTON, Ky. (Nov. 16, 2015) — “In the state with the highest incidence and mortality rates of lung cancer, a collaborative project is taking a multipronged approach to address the continuum of the disease, from prevention to screening to survivorship care. The Kentucky LEADS (Lung cancer. Education. Awareness. Detection. Survivorship) Collaborative, a joint effort of the University of Kentucky, University of Louisville and Lung Cancer Alliance, today announces details of three new statewide programs to reduce the burden of lung cancer in the Commonwealth. The project is the first of its kind to unite an interdisciplinary team of community partners and lung cancer prevention and control experts, creating a unique opportunity for Kentucky to lead in the area of lung cancer survivorship research and programming.”

Lung cancer surgery rates differ widely between states

FRIDAY, Nov. 13, 2015 (HealthDay News) – “Rates of surgery to cure lung cancer vary greatly across the United States, a new study finds.

Researchers analyzed data from patients in 38 states and the District of Columbia who were diagnosed with early stage non-small cell lung cancer between 2007 and 2011.”

What Is the Color of the Lung Cancer Ribbon?

Newswise — November 13, 2015 – “Most people are aware of the cancer signified by pink, but do they know the ribbon color of lung malignancy, a disease that kills more women each year than breast tumors? It is a bit of a trick question. Lung cancer hides out deep in the chest virtually impossible to touch and lacking nerves to warn its victims with pain. So the lung cancer ribbon is often considered to be clear or pearl colored, hard to find, just like lung cancer. November is Lung Cancer Awareness Month, and prevention and early detection are key.”

New therapies a great help for lung cancer

“When you think of lung cancer, you might automatically assume it only affects people who smoke. While its true that 90 percent of lung cancer cases involve smokers, the American Cancer Society says 10 percent of those who have lung cancer are non-smokers.”

Clinical Trials Actively Recruiting Patients With Lung Cancer

“The information contained in this Clinical Trials Resource Guide includes actively recruiting clinical studies for patients with lung cancer. The trials are investigating DNA, RNA, and protein changes contributing to carcinogenesis; new prevention strategies; combination therapies; radiation, stereotactic, and proton therapy; and surgical measures. All of the studies are listed on the National Institutes of Health website at”

National Plan to Fight the Second-leading Cause of Lung Cancer Announced

American Lung Association, EPA, HUD, HHS and eight other national groups launch strategies to reduce 3,200 deaths from lung cancer by 2020

(November 11, 2015) – Chicago, IL – “Announcing a joint commitment to fight the second leading cause of lung cancer, radon gas, the American Lung Association, U.S. Environmental Protection Agency, U.S. Department of Housing and Urban Development, the U.S. Department of Health and Human Services and eight other national partners released the National Radon Action Plan: A Strategy for Saving Lives. The plan sets out strategies to drive the changes needed to reduce exposure to radon, a naturally occurring, invisible and odorless gas that causes an estimated 21,000 lung cancer deaths annually.”

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)